JAK2 V617F Mouse Cytokine Detection: Comprehensive Testing Services and Technical Guide

JAK2 V617F mouse cytokine detection delivers critical insights into inflammatory signaling, immune dysregulation, and disease progression in myeloproliferative neoplasm (MPN) mouse models. Our comprehensive cytokine testing platform combines ELISA, multiplex bead-based assays, and flow cytometry to quantitatively profile dozens of inflammatory mediators from serum, plasma, and tissue samples. This technical guide outlines sample requirements, detectable analytes, methodologies, and research applications to support your preclinical MPN and JAK inhibitor studies.

Technical Overview

The JAK2 V617F mutation is a somatic gain-of-function substitution in the Janus kinase 2 gene, where valine at position 617 is replaced by phenylalanine within the pseudokinase (JH2) domain. This mutation abrogates autoinhibitory regulation, resulting in constitutive activation of the JAK-STAT signaling pathway. In humans, JAK2 V617F is the hallmark driver mutation in Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

Transgenic and knock-in mouse models expressing human-equivalent JAK2 V617F develop robust MPN-like phenotypes, including erythrocytosis, leukocytosis, splenomegaly, extramedullary hematopoiesis, and bone marrow fibrosis. Importantly, these mice also exhibit a chronic inflammatory state characterized by dysregulated cytokine and chemokine production. Quantitative cytokine detection in JAK2 V617F mice is therefore essential for characterizing inflammatory burden, monitoring disease progression, evaluating therapeutic interventions such as JAK inhibitors, and identifying predictive biomarkers.

Our JAK2 V617F mouse cytokine detection service provides sensitive, quantitative measurement of inflammatory mediators across multiple biological matrices, supported by rigorous quality controls, standard curves calibrated against international reference materials, and comprehensive data reporting.

Testing Samples

Serum

Serum is the most commonly submitted matrix for systemic cytokine profiling in JAK2 V617F mice. Blood is collected via retro-orbital puncture, submandibular bleeding, or terminal cardiac puncture, allowed to clot at room temperature for 30-60 minutes, and centrifuged at 2,000 x g for 10-15 minutes. A minimum volume of 100-200 uL of serum is recommended for multiplex panels, while 50 uL is typically sufficient for single-analyte ELISA. Samples should be aliquoted and stored at -80 degrees Celsius to avoid repeated freeze-thaw cycles.

Plasma

Plasma collection using EDTA or heparin anticoagulants preserves certain labile cytokines and prevents ex vivo release from activated platelets and leukocytes. EDTA plasma is generally preferred over heparinized plasma for multiplex bead-based assays because heparin can interfere with antibody-antigen interactions in some assay formats. Plasma should be separated within 30 minutes of collection via centrifugation at 2,000 x g for 15 minutes at 4 degrees Celsius.

Spleen and Bone Marrow Lysates

Given that the spleen is a primary site of extramedullary hematopoiesis in JAK2 V617F mice, splenic cytokine levels often exceed circulating concentrations and provide localized inflammatory information. Tissues are homogenized in protein extraction buffer containing protease inhibitors, clarified by centrifugation, and total protein concentration is determined by BCA assay. Cytokine results are typically normalized to total protein content (pg/mg protein).

Cell Culture Supernatants

Supernatants from primary splenocytes, bone marrow-derived macrophages, or sorted myeloid cell populations stimulated ex vivo can be analyzed to assess cell-intrinsic cytokine production capacity in JAK2 V617F contexts. Collect supernatants after defined stimulation periods, remove cells by centrifugation, and store at -80 degrees Celsius.

Bronchoalveolar and Peritoneal Lavage Fluid

For studies examining inflammatory complications affecting the lung or peritoneal cavity, lavage fluids can be analyzed with minimal dilution to detect locally produced cytokines and chemokines.

Testing Items

We offer detection of a comprehensive panel of mouse cytokines, chemokines, and growth factors relevant to JAK2 V617F-driven inflammation and MPN pathobiology:

• Pro-inflammatory cytokines: IL-1 beta, IL-6, IL-12p70, IL-12p40, TNF-alpha, IFN-gamma
• Anti-inflammatory and regulatory cytokines: IL-4, IL-10, IL-13, TGF-beta 1
• T helper cell signature cytokines: IL-2, IL-5, IL-17A, IL-22, IL-23
• Chemokines: MCP-1 (CCL2), MIP-1 alpha (CCL3), MIP-1 beta (CCL4), RANTES (CCL5), KC (CXCL1), IP-10 (CXCL10), MIG (CXCL9), eotaxin (CCL11)
• Hematopoietic and myeloid growth factors: G-CSF, GM-CSF, M-CSF, FLT3L, SCF
• Fibrosis and vascular mediators: VEGF, PDGF-BB, bFGF, osteopontin
• Acute phase and inflammasome-associated analytes: IL-18, SAA, CRP (species-appropriate assays)

Custom panel configurations are available, ranging from focused 6-plex inflammatory panels to comprehensive 30-plus analyte screens, and can be tailored to specific disease models, tissues, or therapeutic questions.

Testing Methods

Sandwich ELISA

Traditional sandwich ELISA remains the gold standard for single-analyte quantification, offering excellent sensitivity (typically 1-10 pg/mL), high specificity from matched antibody pairs, and straightforward implementation. Duplicate or triplicate well measurements are standard, with four-parameter logistic (4PL) curve fitting for concentration calculation.

Multiplex Bead-Based Immunoassays (Luminex xMAP)

Luminex-based multiplexing enables simultaneous quantification of up to dozens of cytokines from as little as 25-50 uL of sample, making it ideal for longitudinal studies in JAK2 V617F mice where sample volumes are limited. Fluorescently encoded magnetic microspheres coated with capture antibodies are incubated with samples, followed by biotinylated detection antibodies and streptavidin-phycoerythrin reporting.

Flow Cytometric Bead Array (CBA)

CBA assays combine bead-based multiplexing with flow cytometric detection, offering flexibility for laboratories with flow cytometer access and the ability to customize analyte combinations.

Electrochemiluminescence Immunoassay (MSD Platform)

Meso Scale Discovery assays provide ultrahigh sensitivity with an extended dynamic range, low sample volume requirements, and excellent performance for low-abundance cytokines such as IL-13 and IL-17A in mouse serum.

qRT-PCR for Cytokine Transcripts

For mechanistic studies, quantitative real-time PCR measuring relative cytokine mRNA expression in sorted cell populations or whole tissues complements protein-level quantification and helps identify the cellular sources of inflammatory mediators.

Applications

Cytokine detection in JAK2 V617F mouse models supports a wide spectrum of preclinical and translational research objectives:

• Characterization of the inflammatory state associated with MPN development and progression, including clonal hematopoiesis-driven inflammation
• Evaluation of JAK inhibitor efficacy, including ruxolitinib, fedratinib, and next-generation selective inhibitors, using cytokine levels as pharmacodynamic biomarkers
• Investigation of the relationship between systemic inflammation and MPN-associated complications such as thrombosis, bone marrow fibrosis, and cardiovascular events
• Discovery and validation of inflammatory biomarkers for disease monitoring and patient stratification
• Assessment of combination immunotherapy strategies targeting inflammatory axes alongside JAK inhibition
• Study of clonal hematopoiesis of indeterminate potential (CHIP) and its contribution to age-related sterile inflammation
• Longitudinal monitoring of disease burden in therapeutic intervention and relapse studies

FAQ

What sample volume is required for multiplex cytokine testing? For Luminex multiplex panels, 25-50 uL of serum or plasma is typically sufficient depending on the number of analytes. Single-analyte ELISA requires approximately 50-100 uL per analyte. We recommend collecting at least 200 uL where possible to allow for repeat testing.

How should samples be stored and shipped? Samples should be aliquoted to avoid freeze-thaw cycles and stored at -80 degrees Celsius. For international or long-distance shipping, samples must be transported on dry ice with temperature monitoring. Avoid hemolyzed samples, as hemolysis can interfere with assay performance.

What controls are included in the testing process? Each assay includes standard curves with reference standards, blank wells, quality control samples at high and low concentrations, and inter-plate calibrators when multiple plates are required. Results failing predefined CV thresholds are repeated at no additional cost.

Can cytokine levels be correlated with hematological parameters in JAK2 V617F mice? Yes. We encourage submission of accompanying complete blood count data (hematocrit, leukocyte counts, platelet counts) and spleen weights so that cytokine profiles can be interpreted in the context of disease burden.

What is the typical turnaround time? Standard ELISA and multiplex testing is completed within 7-10 business days after sample receipt. Larger studies with custom panels or tissue homogenization steps may require 10-15 business days.

How are results reported? Clients receive a comprehensive data report including raw concentration values, standard curve parameters, QC metrics, sample information, and graphical summaries. Cross-study comparisons with prior datasets can be provided upon request.